Interestingly, Cav3.1 was in the top 1% and 2% of overexpressed genes in sarcoma and prostate, respectively, and was increased almost 2-fold in adenocarcinoma of the lung. This evidence concerns the gene CACNA1G and lung adenocarcinoma.